Covid-19 roundup: UK adds $125M to build a new vac­cine man­u­fac­tur­ing cen­ter; Pfiz­er’s $2 bil­lion con­tract sets bench­mark vac­cine price — for bet­ter or worse

Like the US and oth­er coun­tries, the UK has been scram­bling to get in the front of the line for sup­plies of new Covid-19 vac­cines …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.